Congratulations to Morgan Pugh-Toole at @dalhousieu for receiving a 2023/24 Doctoral Scotia Scholars Award for #research investigating the role for a natural killer cell-based #immunotherapy for high-grade serous carcinoma in an engineered tumor microenvironment.

🧵(1/5)

Psst... ovarian cancer research community: mark your calendars for the Canadian Conference on Ovarian Cancer research, May 24-26 2024, in Sunny (we hope) Halifax: ovariancanada.org/events/ccocr
Ovarian Cancer Canada

That is a wrap! Thank you to all the keynotes Joseph Sun Lab Waggoner Lab Jeanette Boudreau (she/her), speakers, sponsors, and organisers who made #CanNKC2023 possible! See you next year!

We interviewed Dr. Jeanette Boudreau (she/her), scientific director at the BHCRI Research and associate professor at Dalhousie University in Halifax, to learn more about her work in harnessing the power of natural killer (NK) cells for #immunotherapy in #ovariancancers . bit.ly/BoudreauNKCells

We are excited to be hosting our first CanNKC symposium in Hamilton, Ontario this year! Exciting keynote speaker reveals coming soon! Register for the symposium here: 2023cannkcsymposium.rsvpify.com #CanNKC2023

Amazing things happen when scientists that treat patients partner with those who make #innovation , like at the Ovarian Cancer Research Facility, a research center at the edge of health tech.

Their tireless work behind scenes plays an invaluable role in protecting our health 🇨🇦

Today, The Honourable François-Philippe Champagne (FPC) 🇨🇦, Minister of Innovation, Science and Industry, & Andy Fillmore, MP 🇨🇦, Member of Parliament & Parliamentary Secretary for Innovation, Science and Industry, toured the #ovariancancer research labs at Dalhousie University to discover our progress.

Happy to be back at Jeanette Boudreau (she/her)'s ovarian cancer research lab, this time with François-Philippe Champagne (FPC) 🇨🇦. Dr. Boudreau's lab is studying novel ways to treat ovarian cancer. An excellent example of health research happening right here in #Halifax with promising and far-reaching impact!

So excited to finally share this work! Nick Dawe Jeanette Boudreau (she/her) Brendan Leung T-SLICE is a novel in-vitro platform which allows for modeling and study of different tumor microenvironments 🧫🔬

Ever wish you can see how cells behave inside a large tumour? Check out the pre-print of our T-SLICE platform with Jeanette Boudreau (she/her), Morgan Pugh-Toole and Nick Dawe where we cultured and imaged tumour cells within a cell-driven hypoxic TME.

Amazing first conference experience at #CCOCR2022 ! Such an engaging and inspiring weekend and am so proud to have become a part of this amazing group of individuals! Cannot wait for CCOCR 2024 in Halifax! ❤️

Morgan Pugh-Toole and I clean up ok! #CCOCR2022

I am so excited to announce that I’ve been awarded a CIHR CGS-M scholarship for my research with Dr. Jeanette Boudreau Jeanette Boudreau (she/her) and Dr. Brendan Leung Brendan Leung! I am so grateful to my supervisors and lab-mates for their support and can’t wait to see what’s next! 🎉

So excited to share that my first, first-author paper was published! Together with Jeanette Boudreau (she/her) Brendan Leung Sarah Nersesian and Anna Nicolela we discuss the status of HGSC treatment and propose natural killer cells as the missing link in HGSC treatment. link.springer.com/article/10.100…

🙏Luckily we managed to get the lab together for some 🍕+🎁 before omicron hit NS. Big shout out to an absolutely amazing bunch of trainees who made the lab come alive. Congrats on all your achievements this year 👏 👏 👏 Stay healthy and happy holidays to all.